ARCHIVES

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

DCE Advisors OK Recompetitions Worth $10 Mil.

July 19, 1991

NCI programs: AIDS Malignancy Program gets new director, authority.

November 4, 2005

CTRC Wins Renewal Of Cancer Center Grant; New Mexico To Lead Systems Biology Center

September 4, 2009

In Brief: Vicent Bono Retires As Investigational Drugs Branch Chief; Weiss to Leave For Walter Reed

January 9, 1981

Immune System Booster Shown Safe For Prostate Cancer; Fewer Side Effects

August 29, 2008

DCT Board Approves More Than $25 Million In Contract Recompetitions, Two New Contracts

February 23, 1990